GRISULF

This brand name is authorized in Nigeria.

Active ingredients

The drug GRISULF contains one active pharmaceutical ingredient (API):

1
UNII 32HRV3E3D5 - GRISEOFULVIN
 
Read more about Griseofulvin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A11-100557 Cream GRISULF CREAM CREAM 1% 1X30G 33 NF-PP-325623 GRISULF CREAM GRISEOFULVIN 1% W/W Each tube contains Griseofulvin 1% w/w Drugs DERMATOLOGICALS Nigerian Products 1X30G POM 1 4/8/2023 EVERGREEN - MORNING STAR PHARMACEUTICAL IND. LTD, UNOGU COMPOUND, NDIOWERRI VILLAGE ORLU IMO 8037906607 egmpsecdept@gmail.com EVERGREEN MORNING STAR PHARM.IND.LTD, EVERGREEN MORNING STAR INDUSTRIAL COMPLEX NDIOWERRE VILLAGE, ORLU IMO STATE NIGERIA, Nigeria 27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D01BA01 Griseofulvin D Dermatologicals → D01 Antifungals for dermatological use → D01B Antifungals for systemic use → D01BA Antifungals for systemic use
Discover more medicines within D01BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A11-100557

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈